Skip to main content

Peer Review reports

From: Plasma HER2ECD a promising test for patient prognosis and prediction of response in HER2 positive breast cancer: results of a randomized study - SAKK 22/99

Original Submission
22 Jun 2019 Submitted Original manuscript
26 Jul 2019 Reviewed Reviewer Report - Elda Tagliabue
8 Aug 2019 Reviewed Reviewer Report - Angelo Paradiso
6 Nov 2019 Reviewed Reviewer Report - William Jacot
9 Dec 2019 Author responded Author comments - Serenella Eppenberger-Castori
Resubmission - Version 2
9 Dec 2019 Submitted Manuscript version 2
20 Dec 2019 Reviewed Reviewer Report - Elda Tagliabue
3 Jan 2020 Reviewed Reviewer Report - William Jacot
19 Jan 2020 Author responded Author comments - Serenella Eppenberger-Castori
Resubmission - Version 3
19 Jan 2020 Submitted Manuscript version 3
24 Jan 2020 Author responded Author comments - Serenella Eppenberger-Castori
Resubmission - Version 4
24 Jan 2020 Submitted Manuscript version 4
29 Jan 2020 Author responded Author comments - Serenella Eppenberger-Castori
Resubmission - Version 5
29 Jan 2020 Submitted Manuscript version 5
Publishing
31 Jan 2020 Editorially accepted
11 Feb 2020 Article published 10.1186/s12885-020-6594-0

You can find further information about peer review here.

Back to article page